Pharmaceutical Technology looks at how Oramed Pharmaceuticals has teamed up with Premas Biotech to develop an alternative to injectable Covid-19 vaccines. Together, the companies have merged to form a joint venture focused on the development of Covid-19 vaccines called Oravax Medical, combining Oramed’s proprietary POD oral delivery technology and Premas’ novel vaccine technology. To read more click here.
